Joe Copia's daytrades/investments and thoughts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Joe Copia who wrote (24133)	2/8/2002 2:24:48 PM
From: Joe Copia	Read Replies (3) of 25711

I hope this is incorrect. It means Pops will be dead in 2 years! The median survival for patients with CMML is about 24 months. There does not appear to be a difference in survival between patients with the myeloproliferative versus the myelodysplastic forms of the disease nor are the number of blasts of prognostic value. Of adult patients who underwent allogeneic bone marrow transplantation the disease-free survival was 39% at 3 years.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next